CBX4 and lung adenocarcinoma: Wang et al. [23] documented a positive correlation between CBX4 and β-catenin at the protein level in human lung adenocarcinoma clinical samples, implying CBX4’s capacity to stimulate Wnt/β-catenin pathway activation.